Fib-04 Score at the End of Treatment in Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin: An Observational Study
Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2017, Vol 3, Issue 7
Abstract
Abstract: FIB-4 Score is a simple formula to predict liver fibrosis based on the standard biochemical / hematological values i.e. AST, ALT, Platelet count and age. The Score lower than 1.45 has a Negative Predictive Value (NPV) of 95% for significant fibrosis i.e. F3-F4 while, a Score of greater than 3.25 has a PPV of 80% for advance fibrosis i.e. F3-F4. So an improvement of FIB-4 Score is a possible indicator of change in liver fibrosis. The objective is to observe the disparity in paired FIB-04 Score in hepatitis C patients treated with pegylated interferon and ribavirin at the beginning of the treatment and at the end of treatment evaluation (ETR).An observational study was carried out in patients with mono-infected, compensated CHC patients ,treated with Pegylated Interferon & Ribavirin for 24weeks to 48 weeks (according to genotype)in a tertiary care hospital (i.e. Baqai Medical University Hospital Nazimabad) from Jan 2010 to March 2015 in a paired manner i.e. before (at beginning) and at the End of treatment evaluation (ETR). Responses were analyzed by using ‘Wilcoxon signed rank test. SPSS 23.00 version was used to analyze data.Fifty eight patients diagnosed with hepatitis C took part in the study out of which 24 were males (41.4%) with mean age 38.8 (22y-60y) and 34 were females (58.6%) with mean age 43.6 (31y-60y). Out of 58 participants, 8 patients were type 1 genotype, 48 patients were type 3 genotype and 1 was type 4. Genotype of 1 participant was not recorded. According to result evaluated, there is a statically significant decrease in FIB04 score from beginning of treatment (M=2.52, SD=1.35) to ETR (M=1.74, SD=1.37) justifying that there is a definite positive change in FIB-04 score (i.e. improvement in fibrosis). Distinct positive change in FIB-4 Score was observed in Chronic Hepatitis C patients treated with pegylated interferon/ribavirin at the end of treatment. Keywords: FIB-04 Score, hepatitis C, ribavirin, pegylated interferon
Authors and Affiliations
Muhammad Imran, Karim Kammeruddin, Nida Sajid, Amjad Iqbal
Keywords
Related Articles
- EP ID EP391728
- DOI -
- Views 60
- Downloads 0
Hypoglycemic and Hypolipidemic Effects of Hoya parasiticaVariegata (Apocynaceae) and Crotalaria pallidaAiton (Fabaceae) Leaves in Aloxane-Induced Type 2 Diabetic Rats
Abstract:Traditional plant treatment for diabetes has produced a rising interest now a day. Therefore, the purpose of this study was to determine the hypoglycemic effect and hypolipidemic properties of the methanolic ext...
Work Attitude and Job Stress Encountered by Clinical Instructors and Hospital Nurses in Cavite"?
Abstract: This paper presents the difference between hospital nurses’ and clinical instructors’ experienced job stress as well as their attitude towards performing their work. Results revealed that clinical instructors e...
Syringe Pumps Connected in Series with or Without a Carrier Infusion –Does It Matter?
Abstract: It is common in the intensive care unit to have many syringe pumps connected to a stopcock manifold and then attached to the port of a central line.The treatment of such critical patients also involves the alte...
Barriers to Reporting Medication Administration Errors among Nurses in Services Hospital Lahore
Abstract:According to the report of Institute of Medicine (IOM) that about 7,000 of death are occur annual because of the medication error which is going worse day by day. The effect of medication error is not good for p...
Recognition System of Herbal Medicine on Mobile Terminal Based on Android Platform
Abstract: In order to recognize the Chinese herbal medicine our side and to provide the help for the Chinese herbal medicine lovers, we design a kind of recognition system of herbal medicine by our mobile terminal based...